Glucagon-like peptide 1 improved glycemic control in type 1 diabetes.

Authors:
Behme MT; Dupré J; McDonald TJ.

Journal:
BMC Endocr Disord

Publication Year: 2003

DOI:
10.1186/1472-6823-3-3

PMCID:
PMC154101

PMID:
12697069

View on PubMed View on PMC View Publisher
Journal Information

Full Title: BMC Endocr Disord

Abbreviation: BMC Endocr Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel.
Lertsakulbunlue S; Sangkool T; Bhuriveth V and 4 more (2024) - Transparency Score: 3/6
Clinical application of combination [<sup>11</sup>C]C-methionine and [<sup>13</sup>N]N-ammonia PET/…
Wang Z; Feng Z; Zhu D and 4 more (2024) - Transparency Score: 3/6
Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.
Fang Y; Mei W; Wang C and 8 more (2024) - Transparency Score: 3/6
Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer.
Zhuang Y; Cai Q; Hu X and 1 more (2024) - Transparency Score: 3/6
Fear of hypoglycemia and illness perception in type II diabetes patients.
Fariba A; Amerzadeh M; Banazadeh M and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests JD received operating support for these studies from Amylin Pharmaceuticals Inc., through an agreement of collaboration with London Health Sciences Research Inc. JD holds a patent entitled "Treatment of Diabetes", assignee London Health Sciences Centre, with issued patents in Europe, EP 0762890B1, and Australia AU 0711611B2, and with pending applications in the US, 08/737,446, and Canada, 2,190,112."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025